Winstar Display, an innovative display solutions provider, has extended its order visibility to the second quarter of 2025. The company has secured significant replenishment orders from existing ...

StanChart points out that traders continue to ignore the fact that non-OPEC supply has slowed more than demand so far in 2024.

Despite the concerns of some on Wall Street, CNBC's Jim Cramer said demand for Nvidia's products isn't slowing down. "The demand is accelerating because the payoff is so great," he said. "According to ...

There is evidence the supply-side of the 2024/25 balance sheets for corn and soybeans is still a moving target, which means there's potential for more market volatility in the next six weeks. On the ...

Making these chips is hard, and a flaw that was found in one of Nvidia's chips over the summer is not helping.

It enables AI agents to achieve a 98% success rate in multi-step tasks, compared to just 24% for agents using traditional methods.

Nvidias AI chips face critical production hurdles, with soaring demand outpacing supply due to advanced packaging challenges. Analysts foresee persistent bottlenecks into 2025, reshaping the ...

By The Learning Network A new collection of graphs, maps and charts organized by topic and type from our “What’s Going On in This Graph?” feature. By The Learning Network Want to learn ...

(Reuters) – Indian tyre maker MRF reported better-than-expected second-quarter profit on Friday, as stronger replacement demand from retail customers outpaced muted sales to carmakers. The company’s ...

The best logo maker is essential for branding your business and standing out online. My team and I have tested the top tools for beginners and professional designers, and everyone in between.

BRUSSELS (Reuters) -Corning faces an EU antitrust investigation over exclusive supply deals with mobile phone makers and raw glass processing companies that may exclude rival glass producers from ...

Lars Fruergaard Jørgensen, president and CEO, said, “The sales growth is driven by increasing demand for our GLP-1 ... expected continued periodic supply constraints and related drug shortage ...